Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for infantile haemangioma
ACTRN12611000004965Phase 2Completed
- Sponsor
- Sydney Children's Hospital
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Capillary Haemangioma comparing Propranolol with Placebo (2 arms). Primary endpoint: Change in infantile haemangioma volume. Started Jun 2009; status: completed.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ACTRN12611000004965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000004965.